Searched for
RANBAXY PHARMACEUTICALS INC
Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...- Cipher, Ranbaxy settle patent litigation with ActavisCipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litiga...
- Complaint against Sun Pharma for anti-trust violations in USSun Pharmaceutical Industries today said it is reviewing a complaint filed against it and its subsidiaries by Meijer Inc alleging anti-trus...
- Ranbaxy launches acne treatment capsules in the US marketRanbaxy Laboratories Inc has announced the launch of Absorica capsules in the strengths of 25 mg and 35 mg in the US market.
- Alembic Pharma surges over 15 pc after USFDA nod for drugShares of Alembic Pharma today gained over 15% as the company received approval from the USFDA for Desvenlafaxine base extended release tab...
- Alembic Pharma gets USFDA nod for antidepressant tabletsAlembic Pharmaceuticals receives approval from the US health regulator for Desvenlafaxine base extended release tablets used for treating m...
- Ranbaxy launches anti-acne drug in the US marketAccording to an analyst, the launch of Absorica would greatly benefit Ranbaxy as there are only 2-3 players currently selling the product i...
- Ranbaxy launches generic version of Evoxac in US marketRanbaxy has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market.
- Ranbaxy Laboratories launches generic Cadeut in the American marketDrug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- Ranbaxy partners with Validus to sell calcium drug in USRanbaxy Laboratories on Thursday said it has entered into an agreement with the US-based Validus Pharma for selling low cost versions of it...
- Ranbaxy gets USFDA nod for generic version of ulcer drugDrug maker Ranbaxy Laboratories today said it has received approval from the US drug regulator for manufacturing and marketing the generic ...
- Ranbaxy Labs receives USFDA for Cefuroxime AxetilRanbaxy Laboratories has received approval from the US Food and Drug Administration to manufacture and market Cefuroxime Axetil for Oral Su...
- Ranbaxy receives nod for Tamsulosin Hydrochloride capsules in CanadaRanbaxy Laboratories has received approval to manufacture and market Tamsulosin Hydrochloride capsules in 0.4 mg strength from Health Canad...
- Ranbaxy recieves US approval for anti-bacterial drugUS Food and Drug Administration's has given the approval to manufacture and market anti-bacterial drug oral Clarithromycin in multiple stre...
- Ranbaxy gets FDA nod for clarithromycinRanbaxy is the first company to have been granted a generic approval for the oral suspension form along with clarithromycin tablets.
- Ranbaxy receives USFDA nod for Amlodipine BesylateCountry's biggest pharmaceutical firm Ranbaxy Laboratories on Wednesday said it has received tentative US Food and Drug Administration (USF...
- Ranbaxy to market second licensed generic in CanadaThe generic fentanyl patch is sold under Ranbaxy's label 'Ran Fentanyl Transdermal System', used for management of persistent and chronic p...
- Ranbaxy ties up with Ipca LaboratoriesPharmaceutical major Ranbaxy on Thursday said it has entered into a strategic alliance with Mumbai-based Ipca Laboratories to develop gener...
- Ranbaxy ties up with US coPharma major Ranbaxy Laboratories Ltd has entered into a strategic partnership with US-based Invagen Pharmaceuticals Inc.
Load More
